November 29, 2021 3:57 PM
HONG KONG (BLOOMBERG) – China’s Covid-zero strategy seems to be proving a boon for its equities as global markets fret over the omicron coronavirus strain. Nowhere is this more evident than in the performance of the nation’s growth-heavy Chinext Index.



